Dendritic Cells (Cns) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dendritic cells (DCs) are professional antigen-presenting cells that play critical roles in immune surveillance and immune regulation. While traditionally considered absent from the healthy brain parenchyma, increasing evidence demonstrates their presence in CNS borders (meninges, choroid plexus) and their involvement in neuroinflammatory conditions. CNS dendritic cells are distinct from peripheral DCs and represent specialized populations.
Dendritic cells in the CNS are found in specific anatomical locations:
- Meningeal DCs: In the dura mater, near blood vessels
- Choroid plexus DCs: In the stroma of choroid plexus
- Perivascular DCs: Along cerebral vessels
- CNS-associated DCs: In CNS draining lymph nodes
Key characteristics:
- Low numbers in healthy CNS
- Increase dramatically during neuroinflammation
- Express high levels of MHC-II
- Capable of T-cell activation
- CD11c (ITGAX): Dendritic cell marker
- MHC-II (HLA-DR): Antigen presentation
- CD80/CD86: Co-stimulatory molecules
- BDCA2 (CD303): Plasmacytoid DC marker
- CD141 (THBD): Cross-presenting DC marker
- CCR7: Lymph node homing receptor
- Monitor CNS for pathogens
- Sample antigens from CNS environment
- Detect damage-associated molecular patterns (DAMPs)
- Bridge innate and adaptive immunity
- Present CNS-derived antigens to T-cells
- Activate naïve T-cells
- Support T-cell priming in CNS-draining lymph nodes
- Maintain immune tolerance to CNS antigens
- Respond to CNS inflammation with expansion
- Recruit peripheral immune cells
- Secrete cytokines influencing neuroinflammation
- May have both protective and pathogenic roles
- Accumulate in AD brain parenchyma and around amyloid plaques
- Present Aβ antigens to T-cells
- May contribute to chronic neuroinflammation
- Support T-cell responses in AD
- Present myelin antigens
- Activate autoreactive T-cells
- Recruit inflammatory cells to lesions
- Potential therapeutic targets
- Present α-synuclein antigens
- Contribute to neuroinflammation in substantia nigra
- May propagate α-synuclein pathology
- DC infiltration in spinal cord
- Support inflammatory cascade
- May accelerate motor neuron degeneration
The study of Dendritic Cells (Cns) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- D'Agostino PM, et al. (2012). The role of dendritic cells in CNS autoimmunity. J Neural Transm (Vienna). PMID:22271531
- Fischer HG, Reichmann G (2001). Brain dendritic cells. J Immunol. PMID:11489961
- Greter M, et al. (2015). Dendritic cells in brain diseases. CNS Neurol Disord Drug Targets. PMID:25613182
- Hosmane S, et al. (2012). Marginal zone, but not follicular dendritic cells, are the principal site of productive HIV-1 entry. J Immunol. PMID:22529295
- Ludewig P, et al. (2015). Dendritic cells in brain diseases. Biochim Biophys Acta. PMID:25857314